In a report published Wednesday, Morgan Stanley analyst David R. Lewis reiterated an Underweight rating and $120.00 price target on C.R. Bard BCR.
In the report, Morgan Stanley noted, “Our less constructive view on Bard hinges on two ideas: (i) We believe investments will take longer and generate lower returns. (ii) Consensus expectations around Lutonix are simply too enthusiastic. Despite recent confirmatory data points, the stock does not reflect this. We remain Underweight.”
C.R. Bard closed on Tuesday at $141.11.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in